Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.

Achieving LLDAS within 12 months of induction therapy may be favourable in patients with severely active SLE. The low frequency of LLDAS attainment in high-risk populations highlights the need for a new strategy for SLE treatment.